Autoregulation of TDP-43 mRNA levels involves interplay between transcription, splicing, and alternative polyA site selection - PubMed (original) (raw)

Autoregulation of TDP-43 mRNA levels involves interplay between transcription, splicing, and alternative polyA site selection

S Eréndira Avendaño-Vázquez et al. Genes Dev. 2012.

Abstract

TDP-43 is a critical RNA-binding factor associated with pre-mRNA splicing in mammals. Its expression is tightly autoregulated, with loss of this regulation implicated in human neuropathology. We demonstrate that TDP-43 overexpression in humans and mice activates a 3' untranslated region (UTR) intron, resulting in excision of the proximal polyA site (PAS) pA(1). This activates a cryptic PAS that prevents TDP-43 expression through a nuclear retention mechanism. Superimposed on this process, overexpression of TDP-43 blocks recognition of pA(1) by competing with CstF-64 for PAS binding. Overall, we uncover complex interplay between transcription, splicing, and 3' end processing to effect autoregulation of TDP-43.

PubMed Disclaimer

Figures

Figure 1.

Figure 1.

_Cis_-acting elements and molecular events in TDP-43 autoregulation. (A) Schematic diagram of TDP-43 illustrating locations of the stop codon (tag), PASs (pA1–4), the TDPBR, and splicing events (in coding sequences, filled lines; in 3′ UTR, dotted lines). Coding regions (black boxes), untranslated sequences (gray boxes), and introns (connecting black lines) are indicated. RT–PCR primers are indicated. (B, left) Schematic representation of the GFP-3′UTR reporters are shown. (Middle) Western blots of GFP reporter protein in normal (−Tet) and TDP-43 overexpression conditions (+Tet) are shown. (Right) The bar chart shows densitometric quantification of protein expression, normalized against DiGFP expression. Mean values are plotted; error bars indicate the SD from at least three independent experiments. (C) 3′ RACE analysis (−Tet and +Tet) for x7 (left) and x7 Δgt-ag (right) reporters using the specific GFPfw and anchor primers (see A). (Right) The schematic representation denotes amplified mRNA isoforms (bands 1 and 2) confirmed by sequence analysis. (D) 3′ RACE analysis of endogenous TDP-43 (−Tet and +Tet). The forward primer annealed to intron 6 (a), while the anchor was used as the reverse primer (see A). (Right) Amplified mRNA isoforms are indicated.

Figure 2.

Figure 2.

Endogenous TDP-43 in mice and humans; mRNA intron 7 splicing, PAS usage, and mRNAs nuclear retention. (A) Schematic representation of human TDP-43. Arrows show the positions of the primers used. 3′ RACE analysis of endogenous TDP-43 before (−Tet) and following (+Tet) TDP-43 transgene induction performed on nuclear (N) and cytoplasmic (C) RNA fractions or following CHX treatment. The forward primer was annealed to intron 6 (a), while the anchor was used as the reverse primer. (Right) The same samples were checked for the amplification of the endogenous variant V2 mRNA using primers b and c as indicated. All PCR products were sequenced to establish their identity. Distribution of p84 and tubulin was analyzed by Western blotting. (B, left) Schematic diagram of mouse TDP-43 showing sequence conservation between humans and mice and detailed alignment of the sequence corresponding to intron 7 splice sites and the various PAS. (Right) 3′ RACE analysis of endogenous murine TDP-43 from control (wild-type [wt]) and transgenic tg A315T mouse brains. The forward primer is annealed on intron 6 (named ma), while the anchor was used as the reverse primer. A representation of amplified mRNA isoforms (bands 1 and 2) is also shown as confirmed by sequencing. HPRT mRNA amplification was used as a control. (Bottom right) Endogenous and transgenic tg A315T protein expression was measured by Western blotting using anti-TDP-43, with anti-tubulin as control.

Figure 3.

Figure 3.

Pol II stalling on the TDPBR sequence. (A) Schematic diagram of TDP-43 showing positions of ChIP probes used. (B) BrU nuclear run-on assay measuring nascent transcription in different regions of endogenous TDP-43 under normal conditions (−Tet) and following TDP-43 overexpression (+Tet). (C,D) ChIP analysis using N20 Pol II and H5 Pol II CTDser2P antibodies probing the same regions of TDP-43.

Figure 4.

Figure 4.

Competition between TDP-43 and CstF-64 across the pA1 site. (A) Nucleotide sequence of TDP-43 pA1 DSE (top) and a hit frequency plot of TDP-43 CLIP data (bottom) (from the University of California at Santa Cruz Genome Browser). (B) RIP analysis of TDP-43 and CstF-64 proteins on endogenous TDP-43 across pA1 under normal (−Tet) and TDP-43 overexpression (+Tet) conditions. (C) RIP for TDP-43 and CstF-64 proteins across the HPRT PAS used as control.

Figure 5.

Figure 5.

Model of TDP-43 autoregulatory mechanism. Under normal conditions, Pol II synthesizes the nascent TDP-43 mRNA from TDP-43, generating two main TDP-43 mRNA isoforms using either pA1 or pA4, which results in efficient TDP-43 protein expression. When the levels of nuclear TDP-43 rise, there is an increase in the binding of TDP-43 to the TDPBR. This promotes a dual effect: increased intron 7 splicing with the physical removal of the pA1 signal, and direct competition with the cleavage polyA factor Cstf-64 over pA1. Moreover, Pol II stalling may lead to premature termination of transcription and rapid degradation.

Similar articles

Cited by

References

    1. Ayala YM, Zago P, D'Ambrogio A, Xu YF, Petrucelli L, Buratti E, Baralle FE 2008. Structural determinants of the cellular localization and shuttling of TDP-43. J Cell Sci 121: 3778–3785 - PubMed
    1. Ayala YM, De Conti L, Avendano-Vazquez SE, Dhir A, Romano M, D'Ambrogio A, Tollervey J, Ule J, Baralle M, Buratti E, et al. 2011. TDP-43 regulates its mRNA levels through a negative feedback loop. EMBO J 30: 277–288 - PMC - PubMed
    1. Barmada SJ, Skibinski G, Korb E, Rao EJ, Wu JY, Finkbeiner S 2010. Cytoplasmic mislocalization of TDP-43 is toxic to neurons and enhanced by a mutation associated with familial amyotrophic lateral sclerosis. J Neurosci 30: 639–649 - PMC - PubMed
    1. Buratti E, Baralle FE 2001. Characterization and functional implications of the RNA binding properties of nuclear factor TDP-43, a novel splicing regulator of CFTR exon 9. J Biol Chem 276: 36337–36343 - PubMed
    1. Buratti E, Baralle FE 2011. TDP-43: New aspects of autoregulation mechanisms in RNA binding proteins and their connection with human disease. FEBS J 278: 3530–3538 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources